Vit D may halt lung function decline

1 June 2009

Vitamin D may slow the progressive decline in the ability to breathe that can occur in people with asthma as a result of human airway smooth  muscle proliferation, according to research from the University of  Pennsylvania, USA.

The group found that calcitriol, a form of vitamin D synthesized  within the body, reduced growth factor-induced HASM proliferation in  cells isolated from both persons with asthma and from persons without  the disease. The proliferation is a part of process called airway  remodeling, which occurs in many people with asthma, and leads to  reduced lung function over time.

The researchers believe that by slowing airway remodeling, they can  prevent or forestall the irreversible decline in breathing that leaves  many asthmatics even more vulnerable when they suffer an asthma attack.   "Calcitriol has recently earned prominence for its anti-inflammatory  effects," said Gautam Damera, who presented the findings at the American  Thoracic annual meeting in San Diego. "But our study is the first to  reveal the potent role of calcitriol in inhibiting ASM proliferation,"  he pointed out.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight